跳至主要内容
临床试验/CTRI/2021/02/031258
CTRI/2021/02/031258招募中未知

: Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma- an up and down sequential allocation study

arayana Nethralaya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 40 ASA I-III children with known or suspected retinoblastoma aged 1-60 months undergoing EUA ± focal therapy

排除标准

  • The exclusion criteria are lack of parental consent, known allergy to dexmedtomidine, nasal discharge, renal or hepatic dysfunction, any serious systemic diseases

研究者

发起方
arayana Nethralaya

相似试验

Effective dose of intranasal dexmedetomidine for... | 临床试验